Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TmEGFR/IL13Ralpha2 01 CAR-T by Kite Pharma for Recurrent Glioblastoma Multiforme (GBM): Likelihood of Approval
TmEGFR/IL13Ralpha2 01 CAR-T is under clinical development by Kite Pharma and currently in Phase I for Recurrent Glioblastoma Multiforme (GBM)....